RAT test
immunorepressive
bivatuzumab
intetumumab
immunodomination
-zumab
amlitelimab
histoantigen
heteroclitic
cergutuzumab
agonistic monoclonal antibody
polyantibody
neoantigen
multiantigen
ozogamicin
antinucleosome
pathoantigen
immunochemistry
antihuman
immunosorbent
polyvalent
vanucizumab
abagovomab
ziltivekimab
pidilizumab
tislelizumab
solitomab
brolucizumab
radioimmunology
sasanlimab
gevokizumab
olaratumab
sintilimab
dinutuximab
toripalimab
ravulizumab
zenocutuzumab
retifanlimab
pozelimab
immunoprobe
antimouse
glembatumumab
immunohistopathologic
cibisatamab
heterophile